We will be in Orlando, Florida from 28-30 June for the Annual SMA Research and Clinical Care Conference

Other news
Written By Stine Krag Brunvold

We will be in Orlando, Florida from 28-30 June for the Annual SMA Research and Clinical Care Conference, the world’s largest meeting dedicated to Spinal Muscular Atrophy (SMA) research and care, to meet and listen to expert physicians, patients and family members about challenges and opportunities in managing and treating SMA.

If you would like to hear more about our working in developing a clinical candidate to treat SMA, please contact us: contact@nmdpharma.com

To learn more here

Stine Krag Brunvold
Previous

Spinal Muscular Atrophy (SMA) Patient Perspective: Our Clinical Trial Manager Thomas Grønnebæk caught up with Claus

Next

NMD Pharma Reports Results from the ESTABLISH Study – an International Observational Study of Neuromuscular Function in Charcot-Marie-Tooth Type 1 and 2